Here, the effects of single agent chemotherapies and their combination as part of the FLOT, CROSS CT and MAGIC chemotherapy regimens on immunogenicity of OGJ tumours were assessed through expression of HMGB1, CRT, MIC-A/B and HLA-DR. The gene discussed is HMGB1; the disease is neoplasm.